We are live on ! Find out more

322 hedge funds and large institutions have $4.52B invested in ResMed in 2013 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 105 increasing their positions, 128 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 36

16% more capital invested

Capital invested by funds: $3.9B → $4.52B (+$622M)

13% more funds holding in top 10

Funds holding in top 10: 89 (+1)

3% more funds holding

Funds holding: 313322 (+9)

15.82% less ownership

Funds ownership: 78.51%62.69% (-16%)

18% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 128

64% less call options, than puts

Call options by funds: $47.2M | Put options by funds: $130M

Holders
322
Holders Change
+9
Holders Change %
+2.88%
% of All Funds
10.44%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.29%
New
48
Increased
105
Reduced
128
Closed
36
Calls
$47.2M
Puts
$130M
Net Calls
-$82.8M
Net Calls Change
-$52.2M

RMD Hedge Fund Activity: Q3 2013 in Review

322 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2013, worth a combined $4.52B — up 16% from $3.9B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new RMD positions and 36 closed out — a net gain of 12 holders — while 105 added to existing stakes and 128 trimmed.

The largest buyer was Invesco, adding an estimated $139M. The largest seller was Westpac Banking Corp, cutting an estimated $1.3B.

  • 322 institutional investors held ResMed (RMD) as of Q3 2013, up from 313 in Q2 2013.
  • Funds reported $4.52B of ResMed stock for Q3 2013, up 16% quarter-over-quarter.
  • 48 funds opened new ResMed positions in Q3 2013 and 36 closed out, a net change of +12 holders.
  • The largest ResMed buyer in Q3 2013 was Invesco, an estimated $139M added.
  • The largest ResMed seller in Q3 2013 was Westpac Banking Corp, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2013.